Skip to main content
. 2012 Dec 6;7(12):e47391. doi: 10.1371/journal.pone.0047391

Table 2. RAMS among patients with virological failure (VL>5.000 copies/ml) amplified and evaluated by genotyping.

Resistance Associated Mutations (RAMs) N (%)
Some RAMs 15/18 (83.3%)
• TAMS (M41L, D67N, K70R, V75I, L210W, T215Y/F, Q151M) 11/15 (73.3%)
• M184V 15/15 (100%)
• NNRTI (K101E, K103N/S, G190A, V108I, Y181C/V, Y188L) 15/15 (100%)